Yahya Choonara to Nanoparticles
This is a "connection" page, showing publications Yahya Choonara has written about Nanoparticles.
Connection Strength
6,614
-
Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS). Int J Pharm. 2024 May 25; 657:124182.
Score: 0,860
-
Dual Rifampicin and Isoniazid Mannose-Decorated Lipopolysaccharide Nanospheres for Macrophage- Targeted Lung Delivery. Curr Drug Deliv. 2023; 20(10):1487-1503.
Score: 0,784
-
In Vivo Evaluation of Praziquantel-Loaded Solid Lipid Nanoparticles against S. mansoni Infection in Preclinical Murine Models. Int J Mol Sci. 2022 Aug 22; 23(16).
Score: 0,765
-
Lipopolysaccharide Nanosystems for the Enhancement of Oral Bioavailability. AAPS PharmSciTech. 2021 Sep 30; 22(7):242.
Score: 0,719
-
A review on engineered magnetic nanoparticles in Non-Small-Cell lung carcinoma targeted therapy. Int J Pharm. 2021 Sep 05; 606:120870.
Score: 0,708
-
Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers. Colloids Surf B Biointerfaces. 2011 Oct 15; 87(2):243-54.
Score: 0,351
-
The Hemocompatibility of Nanoparticles: A Review of Cell-Nanoparticle Interactions and Hemostasis. Cells. 2019 10 07; 8(10).
Score: 0,157
-
Folate-decorated, endostatin-loaded, nanoparticles for anti-proliferative chemotherapy in esophaegeal squamous cell carcinoma. Biomed Pharmacother. 2019 Nov; 119:109450.
Score: 0,156
-
Antineoplastic nano-lipobubbles for passively targeted ovarian cancer therapy. Colloids Surf B Biointerfaces. 2019 May 01; 177:160-168.
Score: 0,149
-
InVitro, Ex Vivo, and In Vivo Evaluation of a Dual pH/Redox Responsive Nanoliposomal Sludge for Transdermal Drug Delivery. J Pharm Sci. 2018 04; 107(4):1028-1036.
Score: 0,138
-
A dual pH/Redox responsive copper-ligand nanoliposome bioactive complex for the treatment of chronic inflammation. Int J Pharm. 2016 Jul 25; 509(1-2):348-359.
Score: 0,124
-
A review of polymeric colloidal nanogels in transdermal drug delivery. Curr Pharm Des. 2015; 21(20):2801-13.
Score: 0,113
-
Design of chitospheres loaded with pristine polymer particles for extended drug delivery via polyelectrolyte complexation and particulate leaching. Int J Pharm. 2015 Feb 01; 479(1):189-206.
Score: 0,113
-
Nanoparticulate strategies for the five R's of traumatic spinal cord injury intervention: restriction, repair, regeneration, restoration and reorganization. Nanomedicine (Lond). 2014 Feb; 9(2):331-48.
Score: 0,106
-
Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors. Int J Nanomedicine. 2014; 9:589-613.
Score: 0,106
-
Ligand-functionalized nanoliposomes for targeted delivery of galantamine. Int J Pharm. 2013 May 01; 448(1):267-81.
Score: 0,100
-
In vivo evaluation of a conjugated poly(lactide-ethylene glycol) nanoparticle depot formulation for prolonged insulin delivery in the diabetic rabbit model. Int J Nanomedicine. 2013; 8:505-20.
Score: 0,099
-
Design and pharmaceutical evaluation of a nano-enabled crosslinked multipolymeric scaffold for prolonged intracranial release of Zidovudine. J Pharm Pharm Sci. 2013; 16(3):470-85.
Score: 0,098
-
Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with ß-amyloid aggregates of Alzheimer's disease. Pharm Res. 2012 Nov; 29(11):3075-89.
Score: 0,094
-
Fabrication, modeling and characterization of multi-crosslinked methacrylate copolymeric nanoparticles for oral drug delivery. Int J Mol Sci. 2011; 12(9):6194-225.
Score: 0,090
-
Ocular drug delivery - a look towards nanobioadhesives. Expert Opin Drug Deliv. 2011 Jan; 8(1):71-94.
Score: 0,085
-
Investigating the effect of polymeric approaches on circulation time and physical properties of nanobubbles. Pharm Res. 2011 Mar; 28(3):494-504.
Score: 0,085
-
Advances in the treatment of neurodegenerative disorders employing nanotechnology. Ann N Y Acad Sci. 2010 Jan; 1184:154-72.
Score: 0,080
-
Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDS. Adv Drug Deliv Rev. 2010 Mar 18; 62(4-5):532-46.
Score: 0,079
-
Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain. Int J Pharm. 2009 Dec 01; 382(1-2):277-90.
Score: 0,078
-
Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol. 2009 Aug; 88(4):272-85.
Score: 0,076
-
In situ thermo-co-electroresponsive mucogel for controlled release of bioactive agent. Int J Pharm. 2019 Mar 25; 559:255-270.
Score: 0,037
-
Chemotherapeutic Efficacy of Implantable Antineoplastic-Treatment Protocols in an Optimal Mouse Model for Human Ovarian Carcinoma Cell Targeting. Int J Mol Sci. 2018 Oct 04; 19(10).
Score: 0,037
-
Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention. Int J Mol Sci. 2018 Mar 04; 19(3).
Score: 0,035
-
Development of a Novel Polymeric Nanocomposite Complex for Drugs with Low Bioavailability. AAPS PharmSciTech. 2018 Jan; 19(1):303-314.
Score: 0,034
-
Polymeric networks for controlled release of drugs: a patent review. Expert Opin Ther Pat. 2016 Jun; 26(6):703-17.
Score: 0,031
-
Design of an Inflammation-Sensitive Polyelectrolyte-Based Topical Drug Delivery System for Arthritis. AAPS PharmSciTech. 2016 Oct; 17(5):1075-85.
Score: 0,030
-
Development and in vivo evaluation of an implantable nano-enabled multipolymeric scaffold for the management of AIDS dementia complex (ADC). Int J Pharm. 2015 Dec 30; 496(2):863-77.
Score: 0,030
-
Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures. Int J Nanomedicine. 2015; 10:2191-206.
Score: 0,029
-
A prospective overview of the essential requirements in molecular modeling for nanomedicine design. Future Med Chem. 2013 May; 5(8):929-46.
Score: 0,025
-
Patenting of nanopharmaceuticals in drug delivery: no small issue. Recent Pat Drug Deliv Formul. 2007; 1(2):131-42.
Score: 0,016